COVID-19 Update

The Alzheimer’s Association and the U.S. POINTER study’s Coordinating Center at Wake Forest University Medical Center are closely monitoring COVID-19 and are acting to ensure the safety of participants and staff, and to protect the scientific integrity of the study to the best of our ability.

Due to the evolving impact of the novel coronavirus (COVID-19), the U.S. POINTER study will be paused March 23 through July 13, 2020.

Study leadership will conduct ongoing evaluation to determine whether this pause needs to be extended. U.S. POINTER participants are encouraged to reach out to the local site’s study team at any time. It is our highest priority to keep the entire U.S. POINTER “family” safe and healthy.

We continue to connect by mail and telephone with individuals who are interested in the study.

The Alzheimer's Association U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) is a two-year clinical trial to evaluate whether lifestyle interventions that simultaneously target many risk factors protect cognitive function in older adults who are at increased risk for cognitive decline. U.S. POINTER is the first such study to be conducted in a large group of Americans across the United States.

Who We Are

Read about U.S. POINTER study leadership and our principal investigators.

Read More

Are You a Candidate?

Find out more about the eligibility requirements and locations of the study.

Learn More

Alzheimer's Resources

Browse helpful Alzheimer's disease information on alz.org.


Find Resources


A Global Effort

In 2014, a large-scale two-year study in Finland in healthy older adults at increased risk of cognitive decline and dementia (the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability, or FINGER Study) reported that a two-year combination therapy simultaneously targeting physical exercise, a healthy diet, cognitive stimulation, and self-monitoring of heart health risk factors had a protective effect on cognitive function. FINGER and U.S. POINTER join other similar efforts around the globe in a worldwide consortium, World Wide FINGERS (WW-FINGERS). WW-FINGERS will align these research efforts focused on the prevention of Alzheimer's disease and other dementias across the globe.

Get U.S. POINTER Information

Whether you are a researcher or potential participant, use this contact information to receive answers to your questions regarding U.S. POINTER.

Email: POINTERinfo@alz.org
Phone: 800.272.3900



Get Involved
Who We Are
Resources
Contact